COLORECTAL ADENOCARCINOMA
Clinical trials for COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug targets Hard-to-Treat gut cancers in early trial
Disease control CompletedThis early-phase study tested a new drug called cabotamig in 33 adults with advanced gastrointestinal cancers (like colon, stomach, liver, or pancreatic cancer) that had stopped responding to standard treatments. The drug works by attaching to a marker on cancer cells and helping…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Arbele Pty Ltd • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Liver pump delivers chemo directly to tumors in colorectal cancer patients
Disease control CompletedThis study tested a treatment for people with colorectal cancer that spread to the liver. A small pump placed under the skin delivers chemotherapy directly to the liver through an artery. The goal was to see if this approach could shrink liver tumors and help patients live longer…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
New combo therapy shows promise against liver metastases in colorectal cancer
Disease control CompletedThis early-phase study tested the safety of combining the immunotherapy drug pembrolizumab with targeted radiation (SBRT) in 15 adults with colorectal cancer that had spread only to the liver. After surgery to remove all visible tumors, participants received the combination to se…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated May 11, 2026 20:49 UTC